Effectiveness of long-acting monoclonal antibodies against laboratory-confirmed RSV in children aged < 24 months and hospitalised for severe acute respiratory infection, European pilot study, 2024 to 2025. - Savulescu C; Ganser I; Nicolay N; Lajot A; Campos S; Martínez-Baz I; Rodrigues AP; Vandromme M; Cara-Rodríguez M; Echeverría A; Gaio V; Parsy MP; et al. (Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin, 2025)